Antimicrobial Hospital Textiles Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Antimicrobial Hospital Textiles Market in 2025 is estimated at USD 9.33 billion. The global market size surpassed USD 8.84 billion in 2024 and is projected to witness a CAGR of over 6.9%, crossing USD 21.05 billion revenue by 2037. North America is expected to attain USD 7.85 billion by 2037, driven by strict healthcare regulations, the presence of robust healthcare infrastructure, and infection control measures.
The antimicrobial hospital textiles market growth can be attributed to rising health issues due to antimicrobial resistance. This drug resistance tends to lower the effect of antimicrobial medicines, resulting in increasing risks of disease spread, disability, severe illness, and death. The World Health Organization (WHO) has recognized antimicrobial resistance as one of the top ten global public health threats, with over 1.27 million deaths directly attributed to drug-resistant infections yearly. This has resulted in healthcare institutions seeking alternative infection prevention methods, including antimicrobial textiles. These textiles can help reduce the need for antibiotics and disinfectants to control the spread of resistant pathogens within healthcare environments.
Hospitals are gradually using technologies such as nanomaterial coatings, which have the potential to decrease microbial contamination. Similarly, the growing investment in the research and development of eco-friendly antimicrobial solutions highlights the significance of antimicrobial textiles in battling AMR. Innovations such as nanotechnology and microencapsulation are crucial since they allow antimicrobial agents to be embedded directly into fibers. This results in general and more effective antimicrobial protection. The use of silver nanoparticles and chitosan coatings and the development of self-sterilizing fabrics have shown great potential in providing long-lasting antimicrobial properties without sacrificing fabric quality. In January 2024, Ahlstrom announced the FDA approval for its next-generation sterilization warp, Reliance Fusion which helps enhance the sterilization of surgical equipment trays at hospitals.
